Read Time:6 Second
The British pharmaceutical giant beat expectations but saw its share price drop on investors’ concerns about lawsuits surrounding its Zantac heartburn medicine
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
